Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
We read with interest the article by Wouters et al1 on mast cells (MCs) that dominate the mucosal inflammatory infiltrate in the intestine of functional GI disorders (FGIDs). Protease-activated receptor 4 (PAR4) is extensively expressed in MCs in allergic inflammation2 and may mediate an antinociceptive effect in gut visceral hyperalgesia.3 We wish to report the potential influence of PAR4 activation on the production of cytokines from MCs that might regulate sensitisation and subsequent heightened pain behaviour in FGIDs.4 ,5
Immunoreactivity for tryptase and PAR4 was analysed in the colonic mucosa of 21 patients with IBS with diarrhoea (IBS-D) and 16 healthy controls (figure 1A, B). Numbers of MCs were obtained by counting tryptase-immunoreactive cells. There were substantial increases in the numbers of both tryptase and PAR4-positive cells seen in IBS-D colonic mucosa compared with those in healthy controls. Double labelling showed that PAR4 is highly expressed in tryptase-staining MCs in the colon of patients with IBS-D.
Contributors ZW, SA and JH designed the overall project. GZ and JH were responsible for acquisition of data. SA, JS and HD performed in vitro experiments. ZW, SA and GZ were responsible for the analysis and interpretation of the data, and drafted the manuscript. All authors revised and approved the final manuscript.
Funding The study was supported by National Natural Science Foundation of China (No. 81371234) and Natural Science Foundation of Shandong Province, China (ZR2013HM032).
Competing interests None declared.
Patient consent Obtained.
Ethics approval The Ethics Committee of the Taishan Medical University.
Provenance and peer review Not commissioned; externally peer reviewed.